AXA S.A. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
AXA S.A. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$596,180
-34.9%
458,600
+57.2%
0.00%
-33.3%
Q4 2022$916,252
-68.0%
291,800
-50.0%
0.00%
-50.0%
Q3 2022$2,859,820
+280.8%
583,600
+1113.3%
0.01%
+200.0%
Q4 2020$751,000
+505.6%
48,100
+267.2%
0.00%
Q3 2020$124,000
-41.5%
13,100
-44.5%
0.00%
Q2 2020$212,00023,6000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders